Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia

[1]  Apekshya Panda,et al.  MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations , 2020, Nucleic Acids Res..

[2]  Mark D. Robinson,et al.  An R-based reproducible and user-friendly preprocessing pipeline for CyTOF data , 2020, F1000Research.

[3]  S. Varambally,et al.  PAICS, a De Novo Purine Biosynthetic Enzyme, Is Overexpressed in Pancreatic Cancer and Is Involved in Its Progression , 2020, Translational oncology.

[4]  Gennady Korotkevich,et al.  Fast gene set enrichment analysis , 2019, bioRxiv.

[5]  J. Byrd,et al.  Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemia. , 2019, Blood.

[6]  Xiao Meng Pei,et al.  Application of NanoString technologies in companion diagnostic development , 2019, Expert review of molecular diagnostics.

[7]  E. Giné,et al.  The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome , 2019, Nature Cancer.

[8]  V. Shoshan-Barmatz,et al.  Metabolic Reprograming Via Silencing of Mitochondrial VDAC1 Expression Encourages Differentiation of Cancer Cells , 2019, Molecular therapy. Nucleic acids.

[9]  M. Vingron,et al.  Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networks , 2019, Molecular systems biology.

[10]  Ludovic C. Gillet,et al.  Sensitive Quantitative Proteomics of Human Hematopoietic Stem and Progenitor Cells by Data-independent Acquisition Mass Spectrometry* , 2019, Molecular & Cellular Proteomics.

[11]  W. Huber,et al.  Energy metabolism is co-determined by genetic variants in chronic lymphocytic leukemia and influences drug sensitivity , 2019, Haematologica.

[12]  James E. Bradner,et al.  Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia. , 2018, Cancer cell.

[13]  Anna Schuh,et al.  TP53 aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics , 2018, Haematologica.

[14]  W. Hofmann,et al.  Accumulation of DNA damage and alteration of the DNA damage response in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia , 2018, Leukemia & lymphoma.

[15]  M. Teitell,et al.  Initial B Cell Activation Induces Metabolic Reprogramming and Mitochondrial Remodeling , 2018, iScience.

[16]  Mark D. Robinson,et al.  diffcyt: Differential discovery in high-dimensional cytometry via high-resolution clustering , 2018, Communications Biology.

[17]  J. Marioni,et al.  Multi‐Omics Factor Analysis—a framework for unsupervised integration of multi‐omics data sets , 2018, Molecular systems biology.

[18]  Mark D. Robinson,et al.  Compensation of Signal Spillover in Suspension and Imaging Mass Cytometry , 2018, Cell systems.

[19]  P. Attwood,et al.  The actions of NME1/NDPK-A and NME2/NDPK-B as protein kinases , 2018, Laboratory Investigation.

[20]  W. Huber,et al.  Proteome-wide identification of ubiquitin interactions using UbIA-MS , 2018, Nature Protocols.

[21]  Lindsey T. Brinton,et al.  BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET Inhibitor. , 2018, Cancer discovery.

[22]  Hui Shen,et al.  DNA methylation loss in late-replicating domains is linked to mitotic cell division , 2018, Nature Genetics.

[23]  C. Plass,et al.  NFATC1 activation by DNA hypomethylation in chronic lymphocytic leukemia correlates with clinical staging and can be inhibited by ibrutinib , 2018, International journal of cancer.

[24]  Andrzej K. Oleś,et al.  Drug-perturbation-based stratification of blood cancer , 2017, The Journal of Clinical Investigation.

[25]  B. Becher,et al.  CyTOF workflow: differential discovery in high-throughput high-dimensional cytometry datasets , 2017, F1000Research.

[26]  Stéphane Chevrier,et al.  AirLab: a cloud-based platform to manage and share antibody-based single-cell research , 2016, Genome Biology.

[27]  Belinda Phipson,et al.  A cross-package Bioconductor workflow for analysing methylation array data , 2016, bioRxiv.

[28]  J. Byrd,et al.  DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia , 2016, Nature Genetics.

[29]  J. Mesirov,et al.  The Molecular Signatures Database Hallmark Gene Set Collection , 2015 .

[30]  Martin A. Nowak,et al.  Mutations driving CLL and their evolution in progression and relapse , 2015, Nature.

[31]  Catherine J. Wu,et al.  Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia. , 2015, Blood.

[32]  Piet Demeester,et al.  FlowSOM: Using self‐organizing maps for visualization and interpretation of cytometry data , 2015, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[33]  H. Dombret,et al.  BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells , 2015, Oncotarget.

[34]  Eli R. Zunder,et al.  A continuous molecular roadmap to iPSC reprogramming through progression analysis of single-cell mass cytometry. , 2015, Cell stem cell.

[35]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[36]  Eli R. Zunder,et al.  Transient partial permeabilization with saponin enables cellular barcoding prior to surface marker staining , 2014, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[37]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[38]  E. Giné,et al.  A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact , 2014, Leukemia.

[39]  Greg Finak,et al.  OpenCyto: An Open Source Infrastructure for Scalable, Robust, Reproducible, and Automated, End-to-End Flow Cytometry Data Analysis , 2014, PLoS Comput. Biol..

[40]  D. Hockenbery,et al.  MYC and mitochondrial biogenesis. , 2014, Cold Spring Harbor perspectives in medicine.

[41]  Alfonso Valencia,et al.  Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia , 2014, Genome research.

[42]  Lukas Burger,et al.  Transcription Factor Occupancy Can Mediate Active Turnover of DNA Methylation at Regulatory Regions , 2013, PLoS genetics.

[43]  N. Chiorazzi,et al.  B cell receptor signaling in chronic lymphocytic leukemia. , 2013, Trends in immunology.

[44]  N. Sonenberg,et al.  mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation. , 2013, Cell metabolism.

[45]  E. Remmerswaal,et al.  IL-21 and CD40L signals from autologous T cells can induce antigen-independent proliferation of CLL cells. , 2013, Blood.

[46]  Catherine J. Wu,et al.  SF3B1 mutations in chronic lymphocytic leukemia. , 2013, Blood.

[47]  E. Campo,et al.  The genomic landscape of chronic lymphocytic leukemia: clinical implications , 2013, BMC Medicine.

[48]  Corey A. Kemper,et al.  Reverse-engineering the genetic circuitry of a cancer cell with predicted intervention in chronic lymphocytic leukemia , 2012, Proceedings of the National Academy of Sciences.

[49]  Alfonso Valencia,et al.  Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia , 2012, Nature Genetics.

[50]  A. Singh,et al.  The epigenetic control of E-box and Myc-dependent chromatin modifications regulate the licensing of lamin B2 origin during cell cycle , 2012, Nucleic acids research.

[51]  G. Smyth,et al.  Camera: a competitive gene set test accounting for inter-gene correlation , 2012, Nucleic acids research.

[52]  J. Viola,et al.  Transcriptional regulation of the c-Myc promoter by NFAT1 involves negative and positive NFAT-responsive elements , 2012, Cell cycle.

[53]  G. Packham,et al.  Surface IgM stimulation induces MEK1/2-dependent MYC expression in chronic lymphocytic leukemia cells. , 2012, Blood.

[54]  Vijay K. Tiwari,et al.  DNA-binding factors shape the mouse methylome at distal regulatory regions , 2011, Nature.

[55]  A. Sivachenko,et al.  SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. , 2011, The New England journal of medicine.

[56]  T. Ideker,et al.  Subnetwork-based analysis of chronic lymphocytic leukemia identifies pathways that associate with disease progression. , 2011, Blood.

[57]  G. Packham,et al.  B-cell receptor signaling in chronic lymphocytic leukemia. , 2011, Blood.

[58]  Regina K. Cheung,et al.  Screening: CyTOF—the next generation of cell detection , 2011, Nature Reviews Rheumatology.

[59]  Juliane C. Dohm,et al.  Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia , 2011, Nature.

[60]  A. Baccarelli,et al.  Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia , 2011, Epigenetics.

[61]  H. Döhner,et al.  TP53 mutation and survival in chronic lymphocytic leukemia. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  G. Leone,et al.  The proliferative response to CpG-ODN stimulation predicts PFS, TTT and OS in patients with chronic lymphocytic leukemia. , 2010, Leukemia research.

[63]  E. Giné,et al.  Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (“accelerated” chronic lymphocytic leukemia) with aggressive clinical behavior , 2010, Haematologica.

[64]  C. Glass,et al.  Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. , 2010, Molecular cell.

[65]  Trevor Hastie,et al.  Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.

[66]  Anil Potti,et al.  A Genomic Approach to Improve Prognosis and Predict Therapeutic Response in Chronic Lymphocytic Leukemia , 2009, Clinical Cancer Research.

[67]  Kou-Juey Wu,et al.  Direct regulation of HSP60 expression by c‐MYC induces transformation , 2008, FEBS letters.

[68]  Zhiping Weng,et al.  Global mapping of c-Myc binding sites and target gene networks in human B cells , 2006, Proceedings of the National Academy of Sciences.

[69]  Marc K Hellerstein,et al.  In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. , 2005, The Journal of clinical investigation.

[70]  Martin Vingron,et al.  Variance stabilization applied to microarray data calibration and to the quantification of differential expression , 2002, ISMB.

[71]  C. Miething,et al.  Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27 , 2002, Leukemia.

[72]  C. Peschel,et al.  Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells. , 2000, Blood.

[73]  N. Chiorazzi,et al.  Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. , 1999, Blood.

[74]  T J Hamblin,et al.  Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. , 1999, Blood.

[75]  F. Grosso,et al.  Promising in vivo efficacy of the BET bromodomain inhibitor OTX015/MK‐8628 in malignant pleural mesothelioma xenografts , 2017, International journal of cancer.

[76]  Malgorzata Nowicka,et al.  CyTOF workflow: differential discovery in high-throughput high-dimensional cytometry datasets. , 2017, F1000Research.

[77]  Belinda Phipson,et al.  A cross-package Bioconductor workflow for analysing methylation array data. , 2016, F1000Research.

[78]  J. Mesirov,et al.  The Molecular Signatures Database (MSigDB) hallmark gene set collection. , 2015, Cell systems.

[79]  Bernd Bodenmiller,et al.  A practical guide to multiplexed mass cytometry. , 2014, Current topics in microbiology and immunology.

[80]  Luca Laurenti,et al.  Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. , 2012, Blood.

[81]  Anne-Laure Boulesteix,et al.  An eight-gene expression signature for the prediction of survival and time to treatment in chronic lymphocytic leukemia , 2011, Leukemia.

[82]  H. Döhner,et al.  From pathogenesis to treatment of chronic lymphocytic leukaemia , 2010, Nature Reviews Cancer.

[83]  Terry J. Hamblin,et al.  Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia , 1999 .

[84]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .